| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |